Health In Tech (NASDAQ:HIT – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Sunday.
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Health In Tech in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Health In Tech presently has an average rating of “Moderate Buy” and an average price target of $2.50.
View Our Latest Stock Report on Health In Tech
Health In Tech Price Performance
Health In Tech (NASDAQ:HIT – Get Free Report) last announced its earnings results on Wednesday, November 12th. The company reported $0.01 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.01. The business had revenue of $15.59 million for the quarter, compared to analysts’ expectations of $7.05 million.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the company. XTX Topco Ltd purchased a new position in Health In Tech during the first quarter valued at approximately $59,000. Arete Wealth Advisors LLC acquired a new stake in Health In Tech in the 1st quarter valued at approximately $47,000. Ancora Advisors LLC acquired a new stake in Health In Tech during the 3rd quarter worth approximately $389,000. Two Sigma Investments LP acquired a new position in Health In Tech during the 3rd quarter worth approximately $386,000. Finally, Jane Street Group LLC purchased a new position in Health In Tech in the first quarter valued at approximately $48,000.
Health In Tech Company Profile
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
Featured Stories
- Five stocks we like better than Health In Tech
- There Are Different Types of Stock To Invest In
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- Stock Sentiment Analysis: How it Works
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- What is a Death Cross in Stocks?
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.
